GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Illumina Inc (STU:ILU) » Definitions » E10

Illumina (STU:ILU) E10 : €0.63 (As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Illumina E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Illumina's adjusted earnings per share data for the three months ended in Dec. 2023 was €-1.018. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €0.63 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Illumina's average E10 Growth Rate was -54.10% per year. During the past 3 years, the average E10 Growth Rate was -41.90% per year. During the past 5 years, the average E10 Growth Rate was -21.30% per year. During the past 10 years, the average E10 Growth Rate was 20.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Illumina was 234.70% per year. The lowest was -41.90% per year. And the median was 44.20% per year.

As of today (2024-04-30), Illumina's current stock price is €115.82. Illumina's E10 for the quarter that ended in Dec. 2023 was €0.63. Illumina's Shiller PE Ratio of today is 183.84.

During the past 13 years, the highest Shiller PE Ratio of Illumina was 3742.00. The lowest was 43.45. And the median was 134.35.


Illumina E10 Historical Data

The historical data trend for Illumina's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Illumina E10 Chart

Illumina Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.75 2.82 3.65 1.37 0.63

Illumina Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.37 1.35 1.24 0.79 0.63

Competitive Comparison of Illumina's E10

For the Diagnostics & Research subindustry, Illumina's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Illumina's Shiller PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Illumina's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Illumina's Shiller PE Ratio falls into.



Illumina E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Illumina's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-1.018/129.4194*129.4194
=-1.018

Current CPI (Dec. 2023) = 129.4194.

Illumina Quarterly Data

per share eps CPI Adj_EPS
201403 0.289 99.695 0.375
201406 0.228 100.560 0.293
201409 0.489 100.428 0.630
201412 0.835 99.070 1.091
201503 0.850 99.621 1.104
201506 0.615 100.684 0.791
201509 0.704 100.392 0.908
201512 0.643 99.792 0.834
201603 0.539 100.470 0.694
201606 0.730 101.688 0.929
201609 0.775 101.861 0.985
201612 0.796 101.863 1.011
201703 2.319 102.862 2.918
201706 0.774 103.349 0.969
201709 0.931 104.136 1.157
201712 0.389 104.011 0.484
201803 1.144 105.290 1.406
201806 1.207 106.317 1.469
201809 1.140 106.507 1.385
201812 1.239 105.998 1.513
201903 1.389 107.251 1.676
201906 1.761 108.070 2.109
201909 1.435 108.329 1.714
201912 1.449 108.420 1.730
202003 1.059 108.902 1.259
202006 0.284 108.767 0.338
202009 1.027 109.815 1.210
202012 1.438 109.897 1.693
202103 0.840 111.754 0.973
202106 1.046 114.631 1.181
202109 1.768 115.734 1.977
202112 0.628 117.630 0.691
202203 0.499 121.301 0.532
202206 -3.216 125.017 -3.329
202209 -24.503 125.227 -25.323
202212 -0.840 125.222 -0.868
202303 0.019 127.348 0.019
202306 -1.366 128.729 -1.373
202309 -4.469 129.860 -4.454
202312 -1.018 129.419 -1.018

Add all the adjusted EPS together and divide 10 will get our e10.


Illumina  (STU:ILU) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Illumina's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=115.82/0.63
=183.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Illumina was 3742.00. The lowest was 43.45. And the median was 134.35.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Illumina E10 Related Terms

Thank you for viewing the detailed overview of Illumina's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Illumina (STU:ILU) Business Description

Address
5200 Illumina Way, San Diego, CA, USA, 92122
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates about 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (about 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Illumina (STU:ILU) Headlines

No Headlines